Aptagen, LLC
            
                
                    
                                                     
                                            
                                    
                
                                            
            
            
            
            
        
    Apta 3 (ID# 8123)
 
                                            
                            
                            DNA
                        
                    
                                            
                            
                            Carcinoembryonic antigen (CEA)
                        
                    
                                            
                            
                            Protein
                        
                    
                                            
                            
                            60.4 nM (reported value)
                        
                    
                                            
                            
                            Not given.
                        
                    
                                            
                            
                            37°C
                        
                    
                    
                        
                        
                                                            NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.                         
                    
                                            
                            
                            Apta 3 displayed high specificity and affinity for T84 cells (human carcinoma cell line derived from a lung metastasis of a colon carcinoma).
                        
                    
                                    
                
                
                    5’-dTpdCpdGpdCpdGpdCpdGpdApdGpdTpdCpdGpdTpdCpdTpdGpdGpdGpdGpdGpdGpdGpdTpdGpdTpdApdTpdCpdGpdTpdTpdGpdApdCpdGpdApdGpdTpdTpdGpdCpdGpdCpdGpdTpdGpdCpdGpdTpdCpdTpdCpdGpdTpdGpdCpdCpdGpdCpdApdTpdCpdGpdTpdCpdCpdTpdCpdCpdCp-3’
                
                
                     
                
                                    
                        
                        
                            
                    
                
                
                
            
            
         
                
                        
                        70
                    
                
                                    
                        
                        21611.9
                    
                            
                                    
                        
                        631300
                    
                            
                
                
                Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Melo, M.; Correa, C.; Cunha, P.; Goes, A.; Gomes, D.; Andrade, A. DNA aptamers selection for carcinoembryonic antigen (CEA). Bioorg. Med. Chem. Lett. 2020 May 23; 30(15): 127278. DOI: 10.1016/j.bmcl.2020.127278
Have your aptamer oligo synthesized ORDER



We are always looking for ways to improve. Please tell us what you think.